Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2002;47(1):12-7.

[Comparison of linezolid and vancomycin in nosocomial pneumonia: results of the multicenter double-blind study]

[Article in Russian]
S A Grudinina  1 , M M Zubkov, L A Krotova, Iu P Kurdiukova, M A Kutsenko, V F Marinin, S V Sidorenko, A I Sinpal'nikov, A S Solomatin, G V Sterkhova, O V Fesenko, I G Fomina, A G Chuchalin
Affiliations
  • PMID: 12077934
Clinical Trial

[Comparison of linezolid and vancomycin in nosocomial pneumonia: results of the multicenter double-blind study]

[Article in Russian]
S A Grudinina et al. Antibiot Khimioter. 2002.

Abstract

The results of multicenter, randomized, double-blind comparative study of linezolid and vancomycin efficacy, safety and tolerability in the treatment of nosocomial pneumonia are presented. The trial was performed on 69 patients. Clinical efficacy of linezolid was 83 per cent, of vancomycin--79 per cent. Bacteriological effect (pathogen eradication) was 83 per cent for linezolid group and 86 per cent for vancomycin group. During the study good clinical tolerability of linezolid was demonstrated along with lower side effects incidence and shortened recovery period when compared to vancomycin.

PubMed Disclaimer

MeSH terms

LinkOut - more resources